Dataset Information

Ideology and compliance with health guidelines during the COVID-19 pandemic: A comparative perspective.

ABSTRACT: Objective:We measure the prevalence of noncompliance with public health guidelines in the COVID-19 pandemic and examine how it is shaped by political ideology across countries. Methods:A list experiment of noncompliance and a multi-item scale of health-related behaviors were embedded in a comparative survey of 11,000 respondents in nine OCED countries. We conduct a statistical analysis of the list experiment capturing degrees of noncompliance with social distancing rules and estimate ideological effect heterogeneity. A semiparametric analysis examines the functional form of the relationship between ideology and the propensity to violate public health guidelines. Results:Our analyses reveal substantial heterogeneity between countries. Ideology plays an outsized role in the United States. No association of comparable magnitude is found in the majority of the other countries in our study. In many settings, the impact of ideology on health-related behaviors is nonlinear. Conclusion:Our results highlight the importance of taking a comparative perspective. Extrapolating the role of ideology from the United States to other advanced industrialized societies might paint an erroneous picture of the scope of possible nonpharmaceutical interventions. Heterogeneity limits the extent to which policymakers can learn from experiences across borders.

SUBMITTER: Becher M

PROVIDER: S-EPMC8661825 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:The development of the National Institutes of Health (NIH) COVID-19 Treatment Guidelines began in March 2020 in response to a request from the White House Coronavirus Task Force. Within 4 days of the request, the NIH COVID-19 Treatment Guidelines Panel was established and the first meeting took place (virtually-as did subsequent meetings). The Panel comprises 57 individuals representing 6 governmental agencies, 11 professional societies, and 33 medical centers, plus 2 community members, who have worked together to create and frequently update the guidelines on the basis of evidence from the most recent clinical studies available. The initial version of the guidelines was completed within 2 weeks and posted online on 21 April 2020. Initially, sparse evidence was available to guide COVID-19 treatment recommendations. However, treatment data rapidly accrued based on results from clinical studies that used various study designs and evaluated different therapeutic agents and approaches. Data have continued to evolve at a rapid pace, leading to 24 revisions and updates of the guidelines in the first year. This process has provided important lessons for responding to an unprecedented public health emergency: Providers and stakeholders are eager to access credible, current treatment guidelines; governmental agencies, professional societies, and health care leaders can work together effectively and expeditiously; panelists from various disciplines, including biostatistics, are important for quickly developing well-informed recommendations; well-powered randomized clinical trials continue to provide the most compelling evidence to guide treatment recommendations; treatment recommendations need to be developed in a confidential setting free from external pressures; development of a user-friendly, web-based format for communicating with health care providers requires substantial administrative support; and frequent updates are necessary as clinical evidence rapidly emerges.

Project description:BackgroundThe COVID-19 pandemic resulted in a rapid and expansive roll out of telehealth applications as a mode of intervention delivery. The effectiveness of this model of care is currently unclear.ObjectiveA cross-sectional observational study evaluating the Irish physiotherapist's experience of telehealth.MethodIrish Physiotherapists completed an online survey, distributed by the Irish Society of Chartered Physiotherapists (ISCP), exploring considerations and barriers to commencing telehealth, advantages and disadvantages to telehealth, overall experience of telehealth, and their opinion on the future of telehealth. A descriptive approach and conceptual content analysis were used to analysis the data to derive determinants for the continuation of telehealth.ResultsIn total, 205 physiotherapists completed the survey. Seventy-eight per cent were female. Participant's mean age range was 36 to 45 years with 17 years of physiotherapy experience. Eighty-three per cent had no experience with telehealth pre COVID-19. Considerations to commencing telehealth included service user's suitability, adequate technical and organisational resources, physiotherapist's professional conduct, physiotherapist's skills and COVID-19 restrictions. No outstanding barrier to telehealth was identified. Respondents identify that telehealth offered a reduction in travel time for the service user (82%), offer flexibility in the delivery of physiotherapy (81%) and avoid contact with a potential COVID-19 spreader (92%). The limited scope of the physical examination (86%) via telehealth is the significant disadvantage. Telehealth is considered a temporary stop-gap during the COVID-19 pandemic by forty per cent of physiotherapists while sixty per cent consider telehealth as a sustainable alternative mode of health care delivery.ConclusionAt present, health care providers have not universally accepted telehealth as a mode of health care delivery. Our study's findings identify key areas to address to encourage acceptance.

Dataset Information

Ideology and compliance with health guidelines during the COVID-19 pandemic: A comparative perspective.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets